Research Output per year
Fingerprint Dive into the research topics where Thomas Dick is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Mycobacterium tuberculosis
Medicine & Life Sciences
Mycobacterium
Medicine & Life Sciences
Tuberculosis
Medicine & Life Sciences
Mycobacterium smegmatis
Medicine & Life Sciences
Mycobacterium bovis
Medicine & Life Sciences
Pharmaceutical Preparations
Medicine & Life Sciences
Bacillus
Medicine & Life Sciences
Drug Discovery
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1987 2019
1
Citation
(Scopus)
Advancing translational science for pulmonary nontuberculous mycobacterial infections: A road map for research
Daniel-Wayman, S., Abate, G., Barber, D. L., Bermudez, L. E., Coler, R. N., Cynamon, M. H., Daley, C. L., Davidson, R. M., Dick, T., Floto, R. A., Henkle, E., Holland, S. M., Jackson, M., Lee, R. E., Nuermberger, E. L., Olivier, K. N., Ordway, D. J., Prevots, D. R., Sacchettini, J. C., Salfinger, M. & 4 others, , Apr 15 2019, In : American journal of respiratory and critical care medicine. 199, 8, p. 947-951 5 p.Research output: Contribution to journal › Review article
Lung
Infection
Research
Editorial: NTM—The new uber-bugs
Dartois, V., Sizemore, C. & Dick, T., Jan 1 2019, In : Frontiers in Microbiology. 10, JUN, 1299.Research output: Contribution to journal › Editorial
Open Access
Lung Diseases
1
Citation
(Scopus)
Gut microbiota metabolite indole propionic acid targets tryptophan biosynthesis in Mycobacterium tuberculosis
Negatu, D. A., Yamada, Y., Xi, Y., Go, M. L., Zimmerman, M., Ganapathy, U., Dartois, V., Gengenbacher, M. & Dick, T., Mar 1 2019, In : mBio. 10, 2, e02781-18.Research output: Contribution to journal › Article
Open Access
Mycobacterium tuberculosis
Tryptophan
Anthranilate Synthase
indole
propionic acid
6
Citations
(Scopus)
1,3,5-triazaspiro[5.5]undeca-2,4-dienes as selective Mycobacterium tuberculosis dihydrofolate reductase inhibitors with potent whole cell activity
Yang, X., Wedajo, W., Yamada, Y., Dahlroth, S. L., Neo, J. J. L., Dick, T. & Chui, W. K., Jan 20 2018, In : European Journal of Medicinal Chemistry. 144, p. 262-276 15 p.Research output: Contribution to journal › Article
Folic Acid Antagonists
Tetrahydrofolate Dehydrogenase
Mycobacterium tuberculosis
Molecular modeling
Cytotoxicity
2
Citations
(Scopus)
Impact of immunopathology on the antituberculous activity of pyrazinamide
Blanc, L., Sarathy, J. P., Cabrera, N. A., O’Brien, P., Dias‑Freedman, I., Mina, M., Sacchettini, J., Savic, R. M., Gengenbacher, M., Podell, B. K., Prideaux, B., Ioerger, T., Dick, T. & Dartois, V., Sep 1 2018, In : Journal of Experimental Medicine. 215, 8, p. 1975-1986 12 p.Research output: Contribution to journal › Article
Pyrazinamide
Tuberculosis
Bacteriology
Mycobacterium tuberculosis
Pharmaceutical Preparations